NO20090910L - Sulfonamid-derivater som adrenerge agonister og muskariniske antagonister - Google Patents
Sulfonamid-derivater som adrenerge agonister og muskariniske antagonisterInfo
- Publication number
- NO20090910L NO20090910L NO20090910A NO20090910A NO20090910L NO 20090910 L NO20090910 L NO 20090910L NO 20090910 A NO20090910 A NO 20090910A NO 20090910 A NO20090910 A NO 20090910A NO 20090910 L NO20090910 L NO 20090910L
- Authority
- NO
- Norway
- Prior art keywords
- adrenergic agonists
- sulfonamide derivatives
- muscarinic antagonists
- disorders
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Det beskrives forbindelser av formel (1) og framgangsmåter for å fremstille disse, samt mellomprodukter anvendt i fremstilling derav, sammensetninger inneholdende 5 disse og anvendelser derav. Forbindelsene ifølge oppfinnelsen er nyttige innen flere sykdommer, forstyrrelser og tilstander, spesielt innen inflammatoriske, allergiske og respirasjonssykdommer, - forstyrrelser og tilstander.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82809906P | 2006-10-04 | 2006-10-04 | |
PCT/IB2007/002896 WO2008041095A1 (en) | 2006-10-04 | 2007-09-21 | Sulfonamide derivatives as adrenergic agonists and muscarinic antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20090910L true NO20090910L (no) | 2009-03-24 |
Family
ID=38947725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090910A NO20090910L (no) | 2006-10-04 | 2009-02-26 | Sulfonamid-derivater som adrenerge agonister og muskariniske antagonister |
Country Status (25)
Country | Link |
---|---|
US (1) | US20080090873A1 (no) |
EP (1) | EP2074094A1 (no) |
JP (1) | JP2010505810A (no) |
KR (1) | KR20090050104A (no) |
CN (1) | CN101522622A (no) |
AP (1) | AP2009004791A0 (no) |
AR (1) | AR063118A1 (no) |
AU (1) | AU2007303909A1 (no) |
BR (1) | BRPI0719270A2 (no) |
CA (1) | CA2665385A1 (no) |
CL (1) | CL2007002791A1 (no) |
CO (1) | CO6180437A2 (no) |
CR (1) | CR10700A (no) |
EA (1) | EA200900337A1 (no) |
IL (1) | IL197244A0 (no) |
MA (1) | MA30778B1 (no) |
MX (1) | MX2009002209A (no) |
NO (1) | NO20090910L (no) |
PE (1) | PE20080831A1 (no) |
RS (1) | RS20090137A (no) |
TN (1) | TN2009000112A1 (no) |
TW (1) | TW200823185A (no) |
UY (1) | UY30617A1 (no) |
WO (1) | WO2008041095A1 (no) |
ZA (1) | ZA200901320B (no) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201036957A (en) | 2009-02-20 | 2010-10-16 | Astrazeneca Ab | Novel salt 628 |
JP5801997B2 (ja) | 2009-07-07 | 2015-10-28 | ファイザー・リミテッドPfizer Limited | 薬品の組合せを吸入するための投薬ユニット、投薬ユニットのパック、および吸入器 |
WO2011061527A1 (en) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases |
WO2011081937A1 (en) | 2009-12-15 | 2011-07-07 | Gilead Sciences, Inc. | Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy |
ITRM20110083U1 (it) | 2010-05-13 | 2011-11-14 | De La Cruz Jose Antonio Freire | Piastra per la costruzione di carrelli per aeroplani |
EP2386555A1 (en) | 2010-05-13 | 2011-11-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities |
GB201016912D0 (en) | 2010-10-07 | 2010-11-24 | Astrazeneca Ab | Novel combination |
EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
SG11201504452WA (en) | 2012-12-18 | 2015-07-30 | Almirall Sa | New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activity |
TWI643853B (zh) | 2013-02-27 | 2018-12-11 | 阿爾米雷爾有限公司 | 同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類 |
TW201517906A (zh) | 2013-07-25 | 2015-05-16 | Almirall Sa | 含有maba化合物和皮質類固醇之組合 |
TWI641373B (zh) | 2013-07-25 | 2018-11-21 | 阿爾米雷爾有限公司 | 具有蕈毒鹼受體拮抗劑和β2腎上腺素受體促效劑二者之活性的2-胺基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽 |
TW201617343A (zh) | 2014-09-26 | 2016-05-16 | 阿爾米雷爾有限公司 | 具有β2腎上腺素促效劑及M3蕈毒拮抗劑活性之新穎雙環衍生物 |
CN106336406B (zh) * | 2015-07-10 | 2020-01-03 | 四川海思科制药有限公司 | 具有β2受体激动及M受体拮抗活性的八氢并环戊二烯衍生物及其在医药上的用途 |
MY196804A (en) | 2016-12-14 | 2023-05-03 | Beijing Showby Pharmaceutical Co Ltd | Class of bifunctional compounds with quaternary ammonium salt structure |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
CA3128468A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd |
WO2019110521A1 (en) * | 2017-12-04 | 2019-06-13 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Fluorophenyl substituted muscarinic receptor ligands with selectivity for m3 over m2 |
CN116033893A (zh) | 2020-06-26 | 2023-04-28 | 迈兰制药英国有限公司 | 包含5-[3-(3-羟基苯氧基)氮杂环丁烷-1-基]-5-甲基-2,2-二苯基己酰胺的制剂 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776983A (en) * | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
PE20040950A1 (es) * | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
JP4767842B2 (ja) * | 2003-04-01 | 2011-09-07 | セラヴァンス, インコーポレーテッド | β2アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有するジアリールメチル化合物および関連化合物 |
ATE435862T1 (de) * | 2003-05-28 | 2009-07-15 | Theravance Inc | Azabicycloalkanverbindungen als muscarinrezeptor antagonisten |
PL1708992T3 (pl) * | 2004-01-22 | 2007-12-31 | Pfizer | Pochodne sulfonamidów do leczenia chorób |
WO2005080375A1 (en) * | 2004-02-13 | 2005-09-01 | Theravance, Inc. | Crystalline form of a biphenyl compound |
TWI374883B (en) * | 2004-08-16 | 2012-10-21 | Theravance Inc | Crystalline form of a biphenyl compound |
-
2007
- 2007-09-21 CA CA002665385A patent/CA2665385A1/en not_active Abandoned
- 2007-09-21 RS RSP-2009/0137A patent/RS20090137A/sr unknown
- 2007-09-21 BR BRPI0719270-3A patent/BRPI0719270A2/pt not_active IP Right Cessation
- 2007-09-21 CN CNA2007800373310A patent/CN101522622A/zh active Pending
- 2007-09-21 KR KR1020097006899A patent/KR20090050104A/ko not_active Application Discontinuation
- 2007-09-21 AU AU2007303909A patent/AU2007303909A1/en not_active Abandoned
- 2007-09-21 MX MX2009002209A patent/MX2009002209A/es not_active Application Discontinuation
- 2007-09-21 EP EP07805009A patent/EP2074094A1/en not_active Withdrawn
- 2007-09-21 AP AP2009004791A patent/AP2009004791A0/xx unknown
- 2007-09-21 EA EA200900337A patent/EA200900337A1/ru unknown
- 2007-09-21 JP JP2009530960A patent/JP2010505810A/ja not_active Withdrawn
- 2007-09-21 WO PCT/IB2007/002896 patent/WO2008041095A1/en active Application Filing
- 2007-09-27 PE PE2007001318A patent/PE20080831A1/es not_active Application Discontinuation
- 2007-09-27 CL CL200702791A patent/CL2007002791A1/es unknown
- 2007-10-02 US US11/906,796 patent/US20080090873A1/en not_active Abandoned
- 2007-10-02 UY UY30617A patent/UY30617A1/es not_active Application Discontinuation
- 2007-10-03 AR ARP070104386A patent/AR063118A1/es not_active Application Discontinuation
- 2007-10-03 TW TW096137048A patent/TW200823185A/zh unknown
-
2009
- 2009-02-24 ZA ZA200901320A patent/ZA200901320B/xx unknown
- 2009-02-25 IL IL197244A patent/IL197244A0/en unknown
- 2009-02-26 NO NO20090910A patent/NO20090910L/no not_active Application Discontinuation
- 2009-03-31 TN TN2009000112A patent/TN2009000112A1/fr unknown
- 2009-03-31 CR CR10700A patent/CR10700A/es not_active Application Discontinuation
- 2009-04-02 CO CO09034044A patent/CO6180437A2/es not_active Application Discontinuation
- 2009-04-03 MA MA31760A patent/MA30778B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AP2009004791A0 (en) | 2009-04-30 |
BRPI0719270A2 (pt) | 2014-03-11 |
TN2009000112A1 (fr) | 2010-08-19 |
CO6180437A2 (es) | 2010-07-19 |
EA200900337A1 (ru) | 2009-10-30 |
UY30617A1 (es) | 2008-05-31 |
RS20090137A (en) | 2010-06-30 |
CR10700A (es) | 2009-04-24 |
CL2007002791A1 (es) | 2008-04-11 |
IL197244A0 (en) | 2009-12-24 |
MX2009002209A (es) | 2009-03-16 |
JP2010505810A (ja) | 2010-02-25 |
AU2007303909A1 (en) | 2008-04-10 |
US20080090873A1 (en) | 2008-04-17 |
KR20090050104A (ko) | 2009-05-19 |
PE20080831A1 (es) | 2008-06-20 |
CN101522622A (zh) | 2009-09-02 |
AR063118A1 (es) | 2008-12-30 |
CA2665385A1 (en) | 2008-04-10 |
TW200823185A (en) | 2008-06-01 |
MA30778B1 (fr) | 2009-10-01 |
WO2008041095A1 (en) | 2008-04-10 |
ZA200901320B (en) | 2010-04-28 |
EP2074094A1 (en) | 2009-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090910L (no) | Sulfonamid-derivater som adrenerge agonister og muskariniske antagonister | |
NO20084005L (no) | Aminderivater | |
ATE463495T1 (de) | Oxadiazolylpyrazolopyrimidine als mglur2- antagonisten | |
NO20062983L (no) | Sulfonamid-derivater for behandling av sykdommer | |
MY139690A (en) | Sulfonamide derivatives for the treatment of diseases. | |
NO20070526L (no) | Kinazolindionderivater som parp-inhibitorer | |
DE602005020655D1 (de) | Carboxamid-spirolactam-cgrp-rezeptor-antagonisten | |
MXPA05012840A (es) | Derivados de 2-amino-piridina utiles para el tratamiento de enfermedades. | |
GEP20125437B (en) | New sulfonamide derivatives as bradykinin antagonists | |
ATE537170T1 (de) | Cgrp-rezeptorantagonisten | |
NO20070557L (no) | Ftalazinderivater som PARP-inhibitorer | |
EA200601462A1 (ru) | Соединения для лечения заболеваний | |
NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor | |
NO20076515L (no) | Hydantoinforbindelser | |
WO2007073303A3 (en) | Novel benzimidazole derivatives as vanilloid receptor 1 (vrl) inhibitors | |
HK1116477A1 (en) | Benzylpiperazine derivatives useful for the treatment of gastrointestinal disorders | |
WO2006078554A3 (en) | Cgrp receptor antagonists | |
WO2008074803A3 (en) | 4-benzyl-l ( 2h) -phthalazinones as h1 receptor antagonists | |
NO20091052L (no) | Diaryleterderivater og anvendelser derav | |
ATE440836T1 (de) | Verbindungen | |
DE602007004327D1 (de) | Einen azepin-kern enthaltende antagonisten des histaminrezeptors | |
NO20081587L (no) | Aerosolformulering for inhalering | |
NO20080839L (no) | Isotopsubstituerte protonpumpeinhibitorer | |
WO2007035823A3 (en) | Partial mglur5 antagonists and methods of use thereof | |
NO20081529L (no) | Naftyridinderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |